There is risk with Insmed.Some think the dog trial and CF trial are "slam dunks"......perhaps you should ask yourself ( for you certainly dont know)....why did Insmed decline to do a CF Phase3 trial in the US?
They have the money, they possibly now have the approved P3 structure now from the FDA.
Insmed has said they will wait to see what the European trial yields before committing to a CF trial in the US. I think their reasons are solid to delay spending money in the US until they have clarity.
NTM is years from launch, that is surely Insmeds bet
Trading is going exactly as planned
If you actually believed what you typed, you would not be on the "sidelines", as you have stated numerous times, pertaining to INSM. Who are you kidding? The longs here are aware of overall risks in investing, and specifically in biotech stocks, imo.
You and rehdvm2004 appear to be spun from the same cloth.